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also found that system doesn’t provide sufficiently correct 
information for both rotation and translation when the angle is higher 
than 3°. Though this issue needs to be investigate further. 
In the second experiment we found a good correlation between EPID 
and AlignRT. Mean difference in the lat, long and vert direction was 
0.052 ± 0.064 cm, 0.030 ± 0.084 cm, -0.130 ± 0.064 cm, respectively. 
Agreement of AlignRT with the couch position was in lat -0.027 ± 
0.043 cm, long 0.003 ± 0.040 cm and vert 0.005 ± 0.050 cm. 
Conclusions: The AlighRT system is accurate and well correlated with 
our EPID verification method thus we will use it in the clinic for 
patient positioning. We have found that accuracy of our treatment 
table on one linac, is more an issue here, not the AlignRT software 
itself. Regarding the AlignRT setup information we have created a 
special protocol. We will use a 3 DOF (translations only) and maximum 
accepted rotation 3°. Any higher detected rotation have to be 
corrected independently. 
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Purpose/Objective: Whole-brain radiation therapy (WBRT) combined 
with a boost on the metastases has been proven to improve treatment 
results in selected patients in contrast to single WBRT. The 
prospective randomized Radiation Therapy Oncology Group study 
9508, analized the effectiveness and toxicity of hypofractionated 
stereotactic radiotherapy (HSRT) in patients with up to three brain 
metastases. We retrospectively evaluated it with Elekta Synergy VMAT 
and a patented system to achieve high quality fusion image and 
immobilization. 
Materials and Methods: The procedure implemented in our service 
consists of an improved thermoplastic immobilization by means of a 
sub-mask of high density silicone. A similar number of CT and axial 
magnetic resonance images were acquired for planning, both taken 
with exactly the same position and immobilization as in simulation, 
with a slice thickness of 2mm. The resulting image fusion was of 
excellent quality.  
The treatment was designed with the inverse module for VMAT of 
Pinnacle v.9 (SmartArc), with multiple arcs performed with Elekta 
Synergy. The dose scheme employed is the Lagerward one: 
[WBRT(20Gy)+SIBmts(40Gy)] / 5 frac . 
Daily patient positioning was checked with IGRT (Elekta XVI). 
Results: The First step was prophylactic whole brain irradiation. We 
planned two arcs VMAT CCW (178º-60º and 300º-182º)with the 
following targets: brain (Dmax=21Gy, weigh=100 and Dmin =20Gy, 
weight=50), eyes (Dmax=10Gy, weight=1). Later on, we focused on 
metastases separately. For this purpose, we removed from the 
optimization the achieved prophylaxis (Optimization Type None) and 
created three supportive structures: VI1=PTV (mts1) +5mm, VI2=PTV 
(mts2) +5mm, Epx=encephallus-VI1-VI2. The targets were: PTVi 
(Dmax=44Gy,weight=100 and Dmin=40Gy weight=50), Epx 
(Dmax=30Gy) and brain stem (Dmax=23Gy). We made a prescription 
for the arcs of the encephalic prophylaxis of 20Gy, plus 20Gy more to 
each one of the metastases. 
Treatment verifications were performed with the Multicube-Matrixx 
system having fulfilled conditions of 3% gamma, 3mm. 
Until now we have treated five patients, being the differences in 
fusion images less than 1mm and mean IGRT correction of 1.13mm. 
Total time spent of the process, including contouring, treatment 
design and verification, without considering the learning curve, is 
about 7 hours. 
Conclusions: HSRT in patients with up to three brain metastases with 
our inmobilization system, IGRT and VMAT can be considered as a 
feasible stereotactic treatment for brain metastases under a 
radiobiological theoretical valuation of the toxicities and the physical 
doses administered to the target. 
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Purpose/Objective: Clinical commissioning of a treatment planning 
system (TPS) with advanced delivery technique (IMRT, VMAT) is a 
labor intensive process requiring effort from the medical physicist 
team as well as considerable machine time. As the commissioning 
itself does not reveal the clinical potential of the TPS, effort should 
be made to combine both aspects towards an efficient introduction 
into a daily clinical routine. Our aim is to define such adaptive 
strategy to provide a quick launch of the Monaco VMAT TPS, while 
maintain safe commissioning strategy. 
Materials and Methods: Different pathologies are identified and 
prioritized for the commissioning, considering the complexity of the 
planning and the demands from a clinical point of view. Parallel to 
this effort, based on commissioning protocols for IMRT [1,2] and VMAT 
[3] all required tests are categorized aligned with the clinical 
complexity. Requirements from two aspects are classified under a 
strategic plan as low, moderate and high complexity stages, allowing 
the responsible physicians, planners and physicists to maximize their 
focus and joint effort in the preparation phase of each level. 
Results: The resulting strategic plan (Figure 1) developed at our 
institution. Corresponding planners are asked to perform planning 
studies with respect to selected pathologies or tumor sites, while 
physicists carry out measurements according to the stage 
requirement. After completing both requirements for each complexity 
level, final stage approval is given by the leading team of our 
department, keeping clear traceability for all teams what milestones 
are achieved. By this strategic plan the clinical commissioning is 
streamlined resulting in the first stage (low complexity) to be ready 
within one month (less than 20 hours machine time) after the Monaco 
VMAT model was ready. During this period knowledge gathered on the 
planning challenges was be used to adapt further tests required at the 





Conclusions: The presented adaptive strategy is a feasible option 
during commissioning of Monaco VMAT. The first few pathologies can 
be treated after ~ 20 hours machine time, and the planning 
knowledge can be used to adapt further stage requirements.  
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Purpose/Objective: In the past decade, intensity modulated radiation 
therapy (IMRT) have been the technique of choice when treating 
cancer due to high target dose conformity and improved sparing of 
normal tissue surroundings. Whilst these treatments are time efficient 
and have good dose conformity, they place great demands on the 
performance of radiotherapy machines and MLC leaf positions. As a 
result, quality assurance (QA) of radiotherapy machines has had to 
cater for these changes in developing new techniques as well as 
reducing the time to perform them. 
